THERAPEUTIC ALTERNATIVES FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C
Not Applicable
- Registration Number
- PER-003-02
- Lead Sponsor
- SCHERING PLOUGH RESEARCH INSTITUTE,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients with chronic hepatitis C.
2) Anti-HCV positive by enzyme immunoassay (ELIZA) of second generation or recombinant Immunoblot (RIBA).
Exclusion Criteria
Any other etiology of liver disease, based on clinical history and biopsy (if necessary), other than chronic hepatitis C.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method